<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Valerie</forename><surname>Biou</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andy</forename><surname>Thompsson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Andersson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Hajdu</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Biochemistry</orgName>
								<orgName type="department" key="dep2">Biomedical Centre</orgName>
								<orgName type="institution">Uppsala University</orgName>
								<address>
									<postBox>Box 576</postBox>
									<postCode>S- 751 23</postCode>
									<settlement>Uppsala</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">T</forename><surname>Hara</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Biochemistry</orgName>
								<orgName type="department" key="dep2">Biomedical Centre</orgName>
								<orgName type="institution">Uppsala University</orgName>
								<address>
									<postBox>Box 576</postBox>
									<postCode>S- 751 23</postCode>
									<settlement>Uppsala</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Lloyd</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Oxford Center for Molecular Sciences</orgName>
								<orgName type="laboratory">Dyson Perrins Laboratory</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<addrLine>South Parks Rd.</addrLine>
									<postCode>OX1 3QY</postCode>
									<settlement>Oxford</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Schofield</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Oxford Center for Molecular Sciences</orgName>
								<orgName type="laboratory">Dyson Perrins Laboratory</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<addrLine>South Parks Rd.</addrLine>
									<postCode>OX1 3QY</postCode>
									<settlement>Oxford</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Dept. of Molecular Biology</orgName>
								<orgName type="department" key="dep2">Biomedical Centre</orgName>
								<orgName type="institution">SLU</orgName>
								<address>
									<postBox>Box 590</postBox>
									<postCode>S-751 24</postCode>
									<settlement>Uppsala</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">12DFF43F1191808893C763C282625E17</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T14:33+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>The penicillin and cephalosporin antibiotics are amongst the most important therapeutic agents in use today. All cephalosporin antibiotics are produced by complex and expensive synthetic modifications of fermented products. The objective of this project is to develop our understanding of the structure and mechanism of the enzyme which catalyses the key step in cephalosporin biosynthesis (deacetoxycephalosporin C synthase, DAOCS) to allow rational engineering of its specificity. Subsequently, the modified enzyme will be introduced into microorganisms so that cephalosporins of choice may be directly fermented without the need for synthetic modification, with concomitant reductions in production costs and toxic byproducts. As a first step toward this goal we are trying to determine the structure of DAOCS at high resolution.</p><p>DAOCS catalyses the expansion of the penicillin nucleus by inserting a carbon atom into the five-membered thiazolidine ring of the core (for a review see <ref type="bibr" target="#b0">Baldwin &amp; Schofield, 1993)</ref> and provides the link between penicillin and cephalosporin biosynthesis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In Eukaryotes</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis of cephalosporins from penicillins</head><p>P penicillin N deacetoxycephalosporin C deacetylcephalosporin C</p><p>DAOCS and the other oxygenases of cephalosporin biosynthetic enzymes use iron and molecular oxygen, but the stoichiometry of their dioxygen utilisation is different to that of the penicillin pathway: only a two electron oxidation of the substrate is achieved for each molecule of dioxygen consumed. In addition, DAOCS requires a-ketoglutarate for catalysis. In each step, one molecule of a-ketoglutarate is transformed into carbon dioxide and succinate. There are so far no structures reported for a-ketoglutaratedependent enzymes.</p><p>DAOCS from Streptomyces clavuligerus has been over-produced in E. coli. Since the enzyme is highly labile and the crystals are oxygen sensitive we were forced to develop very strict routines both for purification and crystallisation. Numerous crystallisation trials finally produced good quality crystals that diffract to 1.6 8, resolution (spacegroup R3, a=b=106.6 A and c= 70.4 A, one molecule in the asymmetric unit).</p><p>We have collected a number of datasets on beamline 19 under various conditions; a native data set to 2.1 A resolution and several derivative data sets. The native data set contains 16 980 reflections to 2.1 A resolution with an Rmerge of 0.038 and 99 % complete in the highest resolution bin (further details will be presented later). Due to a large number of free cysteines it is rather difficult to find good derivatives. The heavy atom search so far resulted in 4-5 possible derivatives sharing one single site. We are presently trying to incorporate data from anomalous and multi-wavelength anomalous diffraction (MAD) experiments to improve phasing but most derivatives are poor anomalous scatterers. We are also investigating the possibility to use a selenomethionine derivative for MAD phasing.</p></div>		</body>
		<back>

			<div type="acknowledgement">
<div><p>Acknowledgements: We thank <rs type="person">Drs. V. Biou</rs> and <rs type="person">A. Thompson</rs> for excellents facilities and support at beam line 19</p></div>
			</div>			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Baldwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Schofield</surname></persName>
		</author>
		<title level="m">The Chemistry of p-Zuctums</title>
		<meeting><address><addrLine>Blackie, London</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1993">1993</date>
			<biblScope unit="page" from="1" to="78" />
		</imprint>
	</monogr>
	<note type="raw_reference">Baldwin, J.E. &amp; Schofield, C. J. (1993) The Chemistry of p-Zuctums (Ed. Page, M.I.) Blackie, London, pp. 1-78.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Substrate specificity of recombinant Streptomyces clavuligerus deacetoxycephalosporin C synthase.</title>
		<author>
			<persName><forename type="first">Nicholas</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">InÃªs</forename><forename type="middle">A C</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Inger</forename><forename type="middle">A</forename><surname>Andersson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Robert</forename><forename type="middle">M</forename><surname>Adlington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jack</forename><forename type="middle">E</forename><surname>Baldwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Steven</forename><forename type="middle">C J</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nicholas</forename><forename type="middle">P</forename><surname>Crouch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">John</forename><forename type="middle">D</forename><surname>Sutherland</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0960-894x(01)80573-4</idno>
	</analytic>
	<monogr>
		<title level="j">Bioorganic &amp; Medicinal Chemistry Letters</title>
		<title level="j" type="abbrev">Bioorganic &amp; Medicinal Chemistry Letters</title>
		<idno type="ISSN">0960-894X</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1595" to="1600" />
			<date type="published" when="1994-07">1994</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Morgan, N., Pereira, I.A.C., Andersson, I., Adlington, R.M., Baldwin, J.E., Cole, S.E., Crouch, N.P. &amp; Sutherland, J.D. (1994). Bioorganic and Medicinal Chemistry Letters 4, 15951600 .</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Crystal structure of isopenicillin N synthase is the first from a new structural family of enzymes</title>
		<author>
			<persName><forename type="first">Peter</forename><forename type="middle">L</forename><surname>Roach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ian</forename><forename type="middle">J</forename><surname>Clifton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vilmos</forename><surname>FÃ¼lÃ¶p</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Karl</forename><surname>Harlos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Geoffrey</forename><forename type="middle">J</forename><surname>Barton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Janos</forename><surname>Hajdu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Inger</forename><surname>Andersson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christopher</forename><forename type="middle">J</forename><surname>Schofield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jack</forename><forename type="middle">E</forename><surname>Baldwin</surname></persName>
		</author>
		<idno type="DOI">10.1038/375700a0</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">375</biblScope>
			<biblScope unit="issue">6533</biblScope>
			<biblScope unit="page" from="700" to="704" />
			<date type="published" when="1995-06">1995b</date>
			<publisher>Springer Science and Business Media LLC</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Roach, P.L., Clifton, I.J., Ftilijp, V., Harlos, K., Barton, G., Hajdu, J., Andersson, I., Schofield, C.J. &amp; Baldwin, J.E. (1995b) Nature, 375, 700-704.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
